Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Proc Natl Acad Sci U S A ; 120(1): e2209973120, 2023 01 03.
Artigo em Inglês | MEDLINE | ID: mdl-36574648

RESUMO

Obesity is a major risk factor for cancer. Conventional thought suggests that elevated adiposity predisposes to heightened inflammatory stress and potentiates tumor growth, yet underlying mechanisms remain ill-defined. Here, we show that tumors from patients with a body mass index >35 carry a high burden of senescent cells. In mouse syngeneic tumor models, we correlated a pronounced accretion of senescent cancer cells with poorly immunogenic tumors when mice were subjected to diet-induced obesity (DIO). Highly immunogenic tumors showed lesser senescence burden suggesting immune-mediated elimination of senescent cancer cells, likely targeted as a consequence of their senescence-associated secretory phenotype. Treatment with the senolytic BH3 mimetic small molecule inhibitor ABT-263 selectively stalled tumor growth in mice with DIO to rates comparable to regular diet-fed mice. Thus, consideration of body adiposity in the selection of cancer therapy may be a critical determinant for disease outcome in poorly immunogenic malignancies.


Assuntos
Senescência Celular , Neoplasias , Camundongos , Animais , Obesidade/complicações
2.
Can Vet J ; 59(12): 1293-1298, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30532286

RESUMO

Treatments for mild forms of equine asthma are extrapolated from those recommended for severe equine asthma (heaves), but little is known about owner's adherence to recommendations and treatment efficacy. The objective was to determine which recommendations are implemented by owners and their perception of the clinical response to treatment. Medical records of 43 horses diagnosed with moderate asthma between 2010 and 2012 were retrieved from the Université de Montréal database. Treatments and perceived responses were recorded by telephone survey, 2 to 35 months after diagnosis. All 33 owners who completed the survey attempted to decrease exposure to dust and half had also administered medication. Twenty-four owners (73%) described a > 50% improvement in the clinical signs. There was no association between a specific treatment and outcome. A majority of owners of pleasure and sport horses with equine asthma perceived improvement when limiting exposure to hay and barn dust (alone or with medications).


Respect des recommandations de traitement et résultats à court terme pour les chevaux d'agrément et de sport atteints d'asthme des équidés. Les traitements pour des formes bénignes d'asthme des équidés sont extrapolés de ceux recommandés pour le traitement de l'asthme des équidés grave (emphysème chronique), mais on en sait encore peu à propos de l'observance des recommandations par les propriétaires et de l'efficacité du traitement. L'objectif consistait à déterminer quelles recommandations sont mises en oeuvre par les propriétaires et leur perception de la réponse clinique au traitement. Les dossiers médicaux de 43 chevaux diagnostiqués avec un asthme modéré entre 2010 et 2012 ont été récupérés de la base de données de l'Université de Montréal. Les traitements et les réactions perçues ont été consignés lors d'un sondage par téléphone, de 2 à 35 mois après le diagnostic. Les 33 propriétaires qui ont répondu au sondage avaient tenté de réduire l'exposition à la poussière et la moitié avaient aussi administré des médicaments. Vingt-quatre propriétaires (73 %) ont décrit une amélioration de > 50 % des signes cliniques. Il n'y avait aucune association entre un traitement spécifique et un résultat. La plupart des propriétaires possédant des chevaux d'agrément et de sport atteints d'asthme modéré ont perçu une amélioration lorsqu'ils limitaient l'exposition à la poussière de foin et de grange (comme seule mesure ou avec des médicaments). lorsqu'ils limitaient l'exposition à la poussière de foin et de grange (comme seule mesure ou avec des médicaments).(Traduit par Isabelle Vallières).


Assuntos
Asma/veterinária , Doenças dos Cavalos/tratamento farmacológico , Doenças dos Cavalos/prevenção & controle , Ração Animal , Criação de Animais Domésticos/estatística & dados numéricos , Animais , Asma/tratamento farmacológico , Asma/prevenção & controle , Dieta/veterinária , Poeira/prevenção & controle , Feminino , Cavalos , Humanos , Masculino , Adesão à Medicação , Quebeque , Inquéritos e Questionários , Resultado do Tratamento
3.
Science ; 379(6627): 45-62, 2023 01 06.
Artigo em Inglês | MEDLINE | ID: mdl-36603072

RESUMO

Age-related macular degeneration is a prevalent neuroinflammatory condition and a major cause of blindness driven by genetic and environmental factors such as obesity. In diseases of aging, modifiable factors can be compounded over the life span. We report that diet-induced obesity earlier in life triggers persistent reprogramming of the innate immune system, lasting long after normalization of metabolic abnormalities. Stearic acid, acting through Toll-like receptor 4 (TLR4), is sufficient to remodel chromatin landscapes and selectively enhance accessibility at binding sites for activator protein-1 (AP-1). Myeloid cells show less oxidative phosphorylation and shift to glycolysis, ultimately leading to proinflammatory cytokine transcription, aggravation of pathological retinal angiogenesis, and neuronal degeneration associated with loss of visual function. Thus, a past history of obesity reprograms mononuclear phagocytes and predisposes to neuroinflammation.


Assuntos
Memória Epigenética , Imunidade Inata , Degeneração Macular , Doenças Neuroinflamatórias , Obesidade , Animais , Camundongos , Citocinas/genética , Imunidade Inata/genética , Doenças Neuroinflamatórias/genética , Doenças Neuroinflamatórias/imunologia , Obesidade/genética , Fagócitos/imunologia , Transcrição Gênica , Degeneração Macular/genética , Degeneração Macular/imunologia , Reprogramação Celular/genética , Receptor 4 Toll-Like/genética
4.
J Clin Invest ; 133(4)2023 02 15.
Artigo em Inglês | MEDLINE | ID: mdl-36787231

RESUMO

Pathological neovascularization in age-related macular degeneration (nvAMD) drives the principal cause of blindness in the elderly. While there is a robust genetic association between genes of innate immunity and AMD, genome-to-phenome relationships are low, suggesting a critical contribution of environmental triggers of disease. Possible insight comes from the observation that a past history of infection with pathogens such as Chlamydia pneumoniae, or other systemic inflammation, can predispose to nvAMD in later life. Using a mouse model of nvAMD with prior C. pneumoniae infection, endotoxin exposure, and genetic ablation of distinct immune cell populations, we demonstrated that peripheral infections elicited epigenetic reprogramming that led to a persistent memory state in retinal CX3CR1+ mononuclear phagocytes (MNPs). The immune imprinting persisted long after the initial inflammation had subsided and ultimately exacerbated choroidal neovascularization in a model of nvAMD. Single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) identified activating transcription factor 3 (ATF3) as a central mediator of retina-resident MNP reprogramming following peripheral inflammation. ATF3 polarized MNPs toward a reparative phenotype biased toward production of proangiogenic factors in response to subsequent injury. Therefore, a past history of bacterial endotoxin-induced inflammation can lead to immunological reprograming within CNS-resident MNPs and aggravate pathological angiogenesis in the aging retina.


Assuntos
Neovascularização de Coroide , Degeneração Macular , Humanos , Microglia/patologia , Retina/patologia , Neovascularização de Coroide/genética , Degeneração Macular/genética , Degeneração Macular/patologia , Inflamação/patologia
5.
EMBO Mol Med ; 13(5): e11754, 2021 05 07.
Artigo em Inglês | MEDLINE | ID: mdl-33876574

RESUMO

Age-related macular degeneration (AMD) in its various forms is a leading cause of blindness in industrialized countries. Here, we provide evidence that ligands for neuropilin-1 (NRP1), such as Semaphorin 3A and VEGF-A, are elevated in the vitreous of patients with AMD at times of active choroidal neovascularization (CNV). We further demonstrate that NRP1-expressing myeloid cells promote and maintain CNV. Expression of NRP1 on cells of myeloid lineage is critical for mitigating production of inflammatory factors such as IL6 and IL1ß. Therapeutically trapping ligands of NRP1 with an NRP1-derived trap reduces CNV. Collectively, our findings identify a role for NRP1-expressing myeloid cells in promoting pathological angiogenesis during CNV and introduce a therapeutic approach to counter neovascular AMD.


Assuntos
Neovascularização de Coroide , Degeneração Macular Exsudativa , Inibidores da Angiogênese , Humanos , Inflamação , Neuropilina-1/genética , Fator A de Crescimento do Endotélio Vascular , Acuidade Visual
6.
Cell Metab ; 33(4): 818-832.e7, 2021 04 06.
Artigo em Inglês | MEDLINE | ID: mdl-33548171

RESUMO

Attenuating pathological angiogenesis in diseases characterized by neovascularization such as diabetic retinopathy has transformed standards of care. Yet little is known about the molecular signatures discriminating physiological blood vessels from their diseased counterparts, leading to off-target effects of therapy. We demonstrate that in contrast to healthy blood vessels, pathological vessels engage pathways of cellular senescence. Senescent (p16INK4A-expressing) cells accumulate in retinas of patients with diabetic retinopathy and during peak destructive neovascularization in a mouse model of retinopathy. Using either genetic approaches that clear p16INK4A-expressing cells or small molecule inhibitors of the anti-apoptotic protein BCL-xL, we show that senolysis suppresses pathological angiogenesis. Single-cell analysis revealed that subsets of endothelial cells with senescence signatures and expressing Col1a1 are no longer detected in BCL-xL-inhibitor-treated retinas, yielding a retina conducive to physiological vascular repair. These findings provide mechanistic evidence supporting the development of BCL-xL inhibitors as potential treatments for neovascular retinal disease.


Assuntos
Senescência Celular , Doenças Retinianas/patologia , Proteína bcl-X/metabolismo , Animais , Apoptose/efeitos dos fármacos , Senescência Celular/efeitos dos fármacos , Cadeia alfa 1 do Colágeno Tipo I/metabolismo , Inibidor p16 de Quinase Dependente de Ciclina/deficiência , Inibidor p16 de Quinase Dependente de Ciclina/genética , Inibidor p16 de Quinase Dependente de Ciclina/metabolismo , Modelos Animais de Doenças , Células Endoteliais/citologia , Células Endoteliais/metabolismo , Feminino , Flavonóis/química , Flavonóis/farmacologia , Flavonóis/uso terapêutico , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Neovascularização Patológica , Doenças Retinianas/tratamento farmacológico , Doenças Retinianas/metabolismo , Tacrolimo/análogos & derivados , Tacrolimo/farmacologia , Proteína bcl-X/antagonistas & inibidores
7.
Aging (Albany NY) ; 12(24): 24836-24852, 2020 12 23.
Artigo em Inglês | MEDLINE | ID: mdl-33361521

RESUMO

MicroRNAs are small non-coding RNAs that post-transcriptionally regulate gene expression. We recently demonstrated that levels of miR-106b were significantly decreased in the vitreous and plasma of patients with neovascular age-related macular degeneration (AMD). Here we show that expression of the miR-106b-25 cluster is negatively regulated by the unfolded protein response pathway of protein kinase RNA-like ER kinase (PERK) in a mouse model of neovascular AMD. A reduction in levels of miR-106b triggers vascular growth both in vivo and in vitro by inducing production of pro-angiogenic factors. We demonstrate that therapeutic delivery of miR-106b to the retina with lentiviral vectors protects against aberrant retinal angiogenesis in two distinct mouse models of pathological retinal neovascularization. Results from this study suggest that miRNAs such as miR-106b have the potential to be used as multitarget therapeutics for conditions characterized by pathological retinal angiogenesis.


Assuntos
Neovascularização de Coroide/genética , Degeneração Macular/genética , MicroRNAs/genética , Neovascularização Retiniana/genética , Animais , Linhagem Celular , Movimento Celular/genética , Neovascularização de Coroide/patologia , Retinopatia Diabética , Modelos Animais de Doenças , Estresse do Retículo Endoplasmático/genética , Células Endoteliais , Queimaduras Oculares , Humanos , Terapia a Laser , Degeneração Macular/patologia , Camundongos , Oxigênio/toxicidade , Neovascularização Retiniana/patologia , Retinopatia da Prematuridade , Resposta a Proteínas não Dobradas/genética , eIF-2 Quinase/genética , eIF-2 Quinase/metabolismo
8.
Science ; 369(6506)2020 08 21.
Artigo em Inglês | MEDLINE | ID: mdl-32820093

RESUMO

In developed countries, the leading causes of blindness such as diabetic retinopathy are characterized by disorganized vasculature that can become fibrotic. Although many such pathological vessels often naturally regress and spare sight-threatening complications, the underlying mechanisms remain unknown. Here, we used orthogonal approaches in human patients with proliferative diabetic retinopathy and a mouse model of ischemic retinopathies to identify an unconventional role for neutrophils in vascular remodeling during late-stage sterile inflammation. Senescent vasculature released a secretome that attracted neutrophils and triggered the production of neutrophil extracellular traps (NETs). NETs ultimately cleared diseased endothelial cells and remodeled unhealthy vessels. Genetic or pharmacological inhibition of NETosis prevented the regression of senescent vessels and prolonged disease. Thus, clearance of senescent retinal blood vessels leads to reparative vascular remodeling.


Assuntos
Envelhecimento/patologia , Retinopatia Diabética/patologia , Armadilhas Extracelulares/imunologia , Vasos Retinianos/patologia , Animais , Senescência Celular , Retinopatia Diabética/imunologia , Modelos Animais de Doenças , Células Endoteliais/imunologia , Células Endoteliais/patologia , Humanos , Inflamação/imunologia , Inflamação/patologia , Camundongos , Camundongos Endogâmicos C57BL , Neutrófilos/imunologia , Vasos Retinianos/imunologia
9.
Sci Immunol ; 3(21)2018 03 16.
Artigo em Inglês | MEDLINE | ID: mdl-29549139

RESUMO

Obesity gives rise to metabolic complications by mechanisms that are poorly understood. Although chronic inflammatory signaling in adipose tissue is typically associated with metabolic deficiencies linked to excessive weight gain, we identified a subset of neuropilin-1 (NRP1)-expressing myeloid cells that accumulate in adipose tissue and protect against obesity and metabolic syndrome. Ablation of NRP1 in macrophages compromised lipid uptake in these cells, which reduced substrates for fatty acid ß-oxidation and shifted energy metabolism of these macrophages toward a more inflammatory glycolytic metabolism. Conditional deletion of NRP1 in LysM Cre-expressing cells leads to inadequate adipose vascularization, accelerated weight gain, and reduced insulin sensitivity even independent of weight gain. Transfer of NRP1+ hematopoietic cells improved glucose homeostasis, resulting in the reversal of a prediabetic phenotype. Our findings suggest a pivotal role for adipose tissue-resident NRP1+-expressing macrophages in driving healthy weight gain and maintaining glucose tolerance.


Assuntos
Tecido Adiposo/metabolismo , Macrófagos/metabolismo , Neuropilina-1/metabolismo , Animais , Síndrome Metabólica/metabolismo , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Obesidade/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA